[RMP and INH plasma levels in comparison to aminotransferase behavior during a tuberculostatic threefold combination therapy].
D002986:Clinical Trials as Topic; D004359:Drug Therapy, Combination; D004977:Ethambutol / Q000627:therapeutic use; D005260:Female; D006801:Humans; D007538:Isoniazid / Q000097:blood* / Q000627:therapeutic use; D008297:Male; D012293:Rifampin / Q000097:blood* / Q000627:therapeutic use; D000637:Transaminases / Q000097:blood*; D014376:Tuberculosis / Q000188:drug therapy*
D004977:Ethambutol; D000637:Transaminases; D007538:Isoniazid; D012293:Rifampin
RMP- und INH-Plasmaspiegel im Vergleich zum Aminotransferasenverhalten unter einer tuberkulostatischen Dreifach-Kombinationstherapie.